Major Industry Participants Enhancing Their Presence in the Veterinary CRO and CDMO Market

The veterinary contract research organization (CRO) and contract development and manufacturing organization (CDMO) sector is set to experience substantial growth in the coming years. Driven by evolving needs in animal health and advancements in technology, this industry promises significant opportunities and transformations. Let's explore the current market size, primary players, emerging trends, and segment-specific insights defining this expanding field.

Projected Market Size Expansion in the Veterinary CRO and CDMO Industry
The veterinary CRO and CDMO market is anticipated to grow robustly, reaching a value of $11.81 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 9.6%, fueled by a range of factors. Key drivers include rising demand for contract research and manufacturing services, technological progress in veterinary drug development, increasing output of veterinary biologics and pharmaceuticals, stricter global regulatory compliance, and a growing focus on precision medicine tailored for animals. Additionally, market trends such as the surge in outsourcing veterinary drug development, the broadening scope of preclinical and clinical trial offerings, heightened demand for regulatory consulting, enhanced analytical and formulation services adoption, as well as amplified post-marketing surveillance and pharmacovigilance activities are anticipated to shape the market outlook during the forecast period.

Download a free sample of the veterinary cro and cdmo market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12080&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Leading Companies Influencing the Veterinary CRO and CDMO Market
Several prominent companies dominate the veterinary CRO and CDMO landscape, including Eurofins Scientific SE, Charles River Laboratories Inc., IDEXX Laboratories Inc., Elanco India Private Limited, Aenova Group, Taconic Bioscience Inc., knoell Germany GmbH, ClinVet International Pty Ltd., VetPharm Inc., Vetio Animal Health Company, Ridgeway Research Ltd., Drayton Animal Health Ltd., KLIFOVET GmbH, Cebiphar, Veterinary Research Management (VRM) Ltd., Vetspin Srl, STATKING Animal Health CRO, Arcoblu S.r.l., Syneos Health Inc., Pharmaceutical Product Development Inc., Inotiv Inc., Promega Corporation, and Triveritas Ltd. As an example of recent market activity, in May 2023, Belgium-based Argenta acquired Midwest Veterinary Services Inc., aiming to broaden their clinical research and manufacturing capabilities. Midwest Veterinary Services specializes in veterinary CRO and CDMO services focused on animal health product development and testing, making this acquisition a strategic move to enhance service portfolios for both firms.

Innovations and Emerging Trends Driving the Veterinary CRO and CDMO Industry
Market leaders are increasingly developing integrated multi-site CDMO networks that offer advanced sterile manufacturing, lyophilization, and specialized dosage forms to improve drug development timelines and facilitate regulatory compliance. These integrated networks unify several manufacturing facilities and cutting-edge technologies-including sterile multidose systems, lyophilization, and flexible packaging-operating under harmonized quality standards to deliver comprehensive pharmaceutical development and production services. A notable example is Meribel Pharma Solutions, a UK-based CDMO that launched operations in April 2025 with a network of 13 facilities across France, Spain, and Sweden. This full-service provider supports drug development from early stages to commercial production and specializes in oral solid dose, preservative-free multidose, and lyophilization technologies for both human and veterinary health sectors.

View the full veterinary cro and cdmo market report:
https://www.thebusinessresearchcompany.com/report/veterinary-cro-and-cdmo-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Segment Analysis and Market Forecast in Veterinary CRO and CDMO Industry
This report categorizes the veterinary CRO and CDMO market into several segments to provide a detailed overview:
1) By Service Type: Discovery, Development, Manufacturing, Packaging and Labeling, Market Approval and Post-marketing
2) By Animal Type: Companion Animals, Livestock Animals
3) By Application: Medicines, Medical Devices, Pharmaceuticals, Biologics, Other Applications

Further detailed subsegments include:
- Discovery: Target Identification, Target Validation, Lead Identification, Lead Optimization
- Development: Preclinical Development, Clinical Development (Phase I, II, III), Regulatory Consulting
- Manufacturing: API Manufacturing, Finished Dose Formulation, Analytical Services
- Packaging and Labeling: Primary Packaging, Secondary Packaging, Label Design and Compliance
- Market Approval and Post-marketing: Regulatory Submissions, Pharmacovigilance, Post-marketing Surveillance

These classifications help provide clarity on the diverse service offerings and market demands shaping the future trajectory of the veterinary CRO and CDMO sector.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.